Free Trial

Curaleaf Q4 2024 Earnings Report

Curaleaf logo
$0.74 -0.03 (-4.23%)
As of 04/7/2025 03:59 PM Eastern

Curaleaf EPS Results

Actual EPS
$0.02
Consensus EPS
-$0.07
Beat/Miss
Beat by +$0.09
One Year Ago EPS
N/A

Curaleaf Revenue Results

Actual Revenue
$331.05 million
Expected Revenue
$331.87 million
Beat/Miss
Missed by -$820.00 thousand
YoY Revenue Growth
N/A

Curaleaf Announcement Details

Quarter
Q4 2024
Time
After Market Closes
Remove Ads

Curaleaf Earnings Headlines

Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Curaleaf Hldgs Inc. (CURLF) Stock Forecasts
Curaleaf price target lowered to $6.50 from $8 at Seaport Research
See More Curaleaf Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Curaleaf? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Curaleaf and other key companies, straight to your email.

About Curaleaf

Curaleaf (OTCMKTS:CURLF) operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

View Curaleaf Profile

More Earnings Resources from MarketBeat